ECOLAB INC. (ECL) Form 8-K — Oct 27, 2026
Ecolab reported Q3 2026 earnings with reported sales of $4,694.8 million, up 13%, and organic sales growth accelerating to 7%, driven by 63% organic growth in Global High-Tech and 17% in Life Sciences. Adjusted diluted EPS rose 5% to $2.18 despite an approximate 10 percentage point headwind from CoolIT acquisition-related amortization and financing costs; reported diluted EPS was $1.95, down 5%. CEO Christophe Beck called the quarter an inflection point, noting volume growth of 2% despite Middle East disruptions and pricing that accelerated to 5%, stabilizing organic gross margin.
Key figures
- Eps
- 1.95
- Guidance
- FY2026 adjusted diluted EPS $8.10-$8.20 (+8-9%); Q4 2026 adjusted diluted EPS $2.13-$2.23 (+2-7%); Q4 reported sales +12-14%, organic +6-7%; 2027 organic sales at upper end of 5-7% target with adjusted OI margin reaching 20%
- Net Income
- 551.3
- Revenue Yoy
- 13%
- Cash Position
- 722.3
- Digital sales
- $129 million, +34%
- Adjusted eps growth
- 5%
- Adjusted diluted eps
- 2.18
- Organic sales growth
- 7%
- Life sciences organic growth
- 17%
- Global high tech organic growth
- 63%
- Organic operating income growth
- 11%
- Organic operating income margin
- 19.6%
- Reported operating income margin
- 17.3%
- Fy2025 adjusted diluted eps comparison
- 7.53
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.